Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Biocon plans February launch for first biosimilar Herceptin

Set to market own version of breast cancer drug in India

- PMLiVE

Boehringer switches diabetes candidate in Zealand collaboration

Will swap ZP2929 for another GLP-1 receptor agonist

Google testing smart contact lens for people with diabetes

Prototype devices use miniaturised electronics to measure glucose levels

- PMLiVE

ICON’s CEO named chair of ACRO

Trade body for clinical research organisation elects Ciaran Murray

- PMLiVE

New year, new attitudes in digital

The real digital innovations in 2014 need to come in our attitudes, not our technologies

Shire Basingstoke

Shire faces $650m loss on Dermagraft sale

Sells struggling foot ulcer treatment to Organogenesis

- PMLiVE

Ipragliflozin beats diabetes rivals to Japanese approval

Astellas drug is first SGLT2 inhibitor backed by country’s regulator

- PMLiVE

Xarelto should not be approved in ACS says FDA panel

Advisory committee votes against new indication for Bayer and J&J’s anticoagulant

- PMLiVE

Journal questions publishing of industry-backed research

Former BMJ editor compares pharma research to tobacco-funded studies

- PMLiVE

Cancer Research UK to recruit its own ‘Wikipedian’

New in-house role will be funded by the Wellcome Trust and supported by Wikimedia UK

- PMLiVE

Horizon appoints board chair

Dr Ian Gilham assumes position full-time

- PMLiVE

This month in 2000: The formation of GSK

The twenty-first century’s first ‘mega merger’

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links